MedTrace Logo

Psychological Study in Children With Mucoviscidosis

NCT05948488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2023-07-17

No results posted yet for this study

Summary

Cystic fibrosis is the most common serious genetic disease in Europe. It is a multi-disciplinary disease, causing multiple organ damage. It is a painful disease and a source of anxiety and depression.

The aim of this study is to assess the link between pain experienced during care and anxiety in children aged over 8 with cystic fibrosis.

Conditions

Interventions

OTHER

Questionnaires

The questionnaires focus on anxiety, fear and quality of life.

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Géraldine LABOURET, MD · University Hospital, Toulouse

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-28
Primary Completion
2022-08-28
Completion
2022-08-28

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05948488 on ClinicalTrials.gov